UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052733
Receipt number R000060083
Scientific Title Study of Work Productivity by Disease Using a health insurance association in Japan
Date of disclosure of the study information 2023/11/08
Last modified on 2023/11/08 17:06:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of Work Productivity by Disease Using a health insurance association in Japan

Acronym

Study of Work Productivity by Disease Using a health insurance association in Japan

Scientific Title

Study of Work Productivity by Disease Using a health insurance association in Japan

Scientific Title:Acronym

Study of Work Productivity by Disease Using a health insurance association in Japan

Region

Japan


Condition

Condition

all diseases

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Cardiology Pneumology Endocrinology and Metabolism
Hematology and clinical oncology Nephrology Neurology
Clinical immunology Psychosomatic Internal Medicine Infectious disease
Geriatrics Surgery in general Gastrointestinal surgery
Hepato-biliary-pancreatic surgery Vascular surgery Chest surgery
Endocrine surgery Breast surgery Obstetrics and Gynecology
Ophthalmology Dermatology Psychiatry
Oto-rhino-laryngology Orthopedics Urology
Oral surgery Neurosurgery Cardiovascular surgery
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Calculating Abcentism, Presentism Based on Duration Prevalence and WPAI by Disease-Classification
Calculating the amount of work loss by disease classification by sex, age, and job

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

WPAI (Absenteeism Presenteeism Total work productivity impairment Total activity impairment)

Key secondary outcomes

the amount of work loss by disease classification by sex, age, and job


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 Persons who agreed to use the secondary data
2 Persons who have registered for kencom app and meet the following criteria
Persons who responded in June 2021 or December 2021.
Persons who were 19 years or older at June and December 2021 questionnaire data were collected.
Persons who answered 'yes' to Q1 of WPAI questionnaire and were confirmed to be employed at the time the June and December 2021 survey data were collected.
Persons who answered 'yes' to Q2-Q6 of WPAI questionnaire at the time of data collection in either June or December 2021.

WPAI Questionnaire
Q1 Are you currently employed? Do you have a remunerated job?
Q2 In the past 7 days, how many hours did you miss from work due to health problems? Please include all the hours you missed because of health problems and all the hours you were late or left early. Do not include time off to participate in this survey.
Q3 In the past 7 days, how many hours did you take off from work for reasons other than health problems, such as holidays and time off to participate in this survey?
Q4 How many hours did you actually work during the past 7 days?
Q5 How much did your health problems affect your productivity while you were working in the past 7 days?
Q6 How much did your health problems affect your daily activities outside of work during the past 7 days?

Key exclusion criteria

Persons who answered "12. student" or "13. unemployed" in Q4 of the questionnaire on job category.

(Occupation Questionnaire)
Q4. What is your type of occupation?
(Choice)
1. professional/technical (doctor, nurse, lawyer, engineer, designer, management consultant, interpreter, editor, etc.)
2. managerial position (managerial positions at the section chief level or above, manager or executive of a company or organization, etc.)
3. clerical work (accounting clerks, sales clerks, receptionists, secretaries, investigators, etc.)
4. sales staff
5. sales jobs
6. transportation and communication occupations (truck and cab drivers, seamen, mail carriers, etc.)
Security occupations (police officers, firefighters, self-defense guards, security guards, etc.)
8. skilled and labor occupations (auto mechanics, construction workers, electricians, etc.)
Agriculture, forestry, and fisheries (crop production, livestock rearing, etc.)
10. service occupations (qualifications required) (hairdressers, care workers, cooks, etc.)
11. service occupations (no qualifications required)
12. student
13. unemployed
14. other

Target sample size

30000


Research contact person

Name of lead principal investigator

1st name Kentaro
Middle name
Last name Yamato

Organization

Otsuka Pharmaceutical Co.,Ltd.

Division name

Medical Affairs

Zip code

108-8241

Address

Shinagawa Grand Central Tower 2-16-4 Konan,Minato-ku, Tokyo 108-8242, Japan

TEL

03-6717-1400

Email

Yamato.Kentaro@otsuka.jp


Public contact

Name of contact person

1st name Kentaro
Middle name
Last name Yamato

Organization

Otsuka Pharmaceutical Co.,Ltd.

Division name

Medical Affairs

Zip code

108-8241

Address

Shinagawa Grand Central Tower 2-16-4 Konan,Minato-ku, Tokyo 108-8242, Japan

TEL

03-6717-1400

Homepage URL


Email

Yamato.Kentaro@otsuka.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Otsuka Pharmaceutical Co.,Ltd. Research Department Research Ethics Committee

Address

10-463 Kagasuno Kawachi cho Tokushima city Tokushima

Tel

088-665-2126

Email

Suzuki.Takashi@otsuka.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 10 Month 17 Day

Date of IRB

2023 Year 10 Month 12 Day

Anticipated trial start date

2023 Year 11 Month 15 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Calculating Abcentism, Presentism Based on Duration Prevalence and WPAI by Disease-Classification


Management information

Registered date

2023 Year 11 Month 08 Day

Last modified on

2023 Year 11 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060083


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name